Dialysate aluminium concentration and renal bone disease

G. S. Walker, J. E. Aaron, Munro Peacock, P. J. Robinson, A. M. Davison

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

We studied 40 patients maintained on regular hemodialysis, using radiology and quantitative bone histology to assess the relationship between renal and bone disease and exposure to aluminium. Fractures were significantly more common in patients exposed to high dialysate aluminium concentrations. The histologic indices of osteomalacia were significantly related to the prevailing dialysate aluminium concentration, in such a way that higher aluminium levels were associated with more osteomalacia. Patients who had been exposed to higher concentrations of aluminium also tended to have a lower plasma phosphate concentration, and associated hypercalcemia was seen in 6 patients with osteomalacia. These findings suggest that aluminium is a toxic agent associated with a mineralizing defect in the bone of renal failure patients. This may explain the incomplete response of some patients with renal osteomalacia to administration of 1,25-dihydroxy vitamin D.

Original languageEnglish (US)
Pages (from-to)411-415
Number of pages5
JournalKidney International
Volume21
Issue number2
StatePublished - 1982
Externally publishedYes

Fingerprint

Bone Diseases
Dialysis Solutions
Aluminum
Osteomalacia
Kidney
Bone and Bones
Poisons
Hypercalcemia
Radiology
Vitamin D
Renal Insufficiency
Renal Dialysis
Histology
Phosphates

ASJC Scopus subject areas

  • Nephrology

Cite this

Walker, G. S., Aaron, J. E., Peacock, M., Robinson, P. J., & Davison, A. M. (1982). Dialysate aluminium concentration and renal bone disease. Kidney International, 21(2), 411-415.

Dialysate aluminium concentration and renal bone disease. / Walker, G. S.; Aaron, J. E.; Peacock, Munro; Robinson, P. J.; Davison, A. M.

In: Kidney International, Vol. 21, No. 2, 1982, p. 411-415.

Research output: Contribution to journalArticle

Walker, GS, Aaron, JE, Peacock, M, Robinson, PJ & Davison, AM 1982, 'Dialysate aluminium concentration and renal bone disease', Kidney International, vol. 21, no. 2, pp. 411-415.
Walker GS, Aaron JE, Peacock M, Robinson PJ, Davison AM. Dialysate aluminium concentration and renal bone disease. Kidney International. 1982;21(2):411-415.
Walker, G. S. ; Aaron, J. E. ; Peacock, Munro ; Robinson, P. J. ; Davison, A. M. / Dialysate aluminium concentration and renal bone disease. In: Kidney International. 1982 ; Vol. 21, No. 2. pp. 411-415.
@article{bbcb35dc1c2547f68dd4aad48f289f82,
title = "Dialysate aluminium concentration and renal bone disease",
abstract = "We studied 40 patients maintained on regular hemodialysis, using radiology and quantitative bone histology to assess the relationship between renal and bone disease and exposure to aluminium. Fractures were significantly more common in patients exposed to high dialysate aluminium concentrations. The histologic indices of osteomalacia were significantly related to the prevailing dialysate aluminium concentration, in such a way that higher aluminium levels were associated with more osteomalacia. Patients who had been exposed to higher concentrations of aluminium also tended to have a lower plasma phosphate concentration, and associated hypercalcemia was seen in 6 patients with osteomalacia. These findings suggest that aluminium is a toxic agent associated with a mineralizing defect in the bone of renal failure patients. This may explain the incomplete response of some patients with renal osteomalacia to administration of 1,25-dihydroxy vitamin D.",
author = "Walker, {G. S.} and Aaron, {J. E.} and Munro Peacock and Robinson, {P. J.} and Davison, {A. M.}",
year = "1982",
language = "English (US)",
volume = "21",
pages = "411--415",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Dialysate aluminium concentration and renal bone disease

AU - Walker, G. S.

AU - Aaron, J. E.

AU - Peacock, Munro

AU - Robinson, P. J.

AU - Davison, A. M.

PY - 1982

Y1 - 1982

N2 - We studied 40 patients maintained on regular hemodialysis, using radiology and quantitative bone histology to assess the relationship between renal and bone disease and exposure to aluminium. Fractures were significantly more common in patients exposed to high dialysate aluminium concentrations. The histologic indices of osteomalacia were significantly related to the prevailing dialysate aluminium concentration, in such a way that higher aluminium levels were associated with more osteomalacia. Patients who had been exposed to higher concentrations of aluminium also tended to have a lower plasma phosphate concentration, and associated hypercalcemia was seen in 6 patients with osteomalacia. These findings suggest that aluminium is a toxic agent associated with a mineralizing defect in the bone of renal failure patients. This may explain the incomplete response of some patients with renal osteomalacia to administration of 1,25-dihydroxy vitamin D.

AB - We studied 40 patients maintained on regular hemodialysis, using radiology and quantitative bone histology to assess the relationship between renal and bone disease and exposure to aluminium. Fractures were significantly more common in patients exposed to high dialysate aluminium concentrations. The histologic indices of osteomalacia were significantly related to the prevailing dialysate aluminium concentration, in such a way that higher aluminium levels were associated with more osteomalacia. Patients who had been exposed to higher concentrations of aluminium also tended to have a lower plasma phosphate concentration, and associated hypercalcemia was seen in 6 patients with osteomalacia. These findings suggest that aluminium is a toxic agent associated with a mineralizing defect in the bone of renal failure patients. This may explain the incomplete response of some patients with renal osteomalacia to administration of 1,25-dihydroxy vitamin D.

UR - http://www.scopus.com/inward/record.url?scp=0020037874&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020037874&partnerID=8YFLogxK

M3 - Article

VL - 21

SP - 411

EP - 415

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 2

ER -